(3)アトピー性皮膚炎

DOI

書誌事項

タイトル別名
  • (3) Atopic Dermatitis

抄録

<p>The pathological condition of atopic dermatitis is formed by three factors: decreased skin barrier function, type 2 immune response, and itching. In recent years, elucidation of the pathological condition of atopic dermatitis has progressed from the immunological aspect. Type 2 cytokines, such as interleukin (IL) -4 and IL-13, produced from cells such as Th2 cells and type 2 innate lymphocytes, play a crucial role in the lesion areas of atopic dermatitis. These type 2 cytokines decrease the antibacterial peptide levels and the barrier of epidermal keratinocytes, and induce inflammation. Currently, antibody preparations that suppress targeted cytokines, Janus kinase (JAK) inhibitors that inhibit the JAK-signal transducer and activator of transcription (STAT) pathway and system, and anti-phosphodiesterase4 (PDE4) inhibitors, developed based on the pathological condition of atopic dermatitis, are on the market. The existing topical drug therapies are the anticipated treatment methods for refractory atopic dermatitis affecting children and adults.</p>

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390018451149723776
  • DOI
    10.24488/jtwmu.94.2_35
  • ISSN
    24326178
    00409022
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ